11573/1669817 - 2021 -
Assessment of resistance mechanisms and clinical implications in patients with kras mutated-metastatic breast cancer and resistance to cdk4/6 inhibitors Raimondi, L.; Raimondi, F. M.; Pietranera, M.; Di Rocco, A.; Di Benedetto, L.; Miele, E.; Lazzeroni, R.; Cimino, G.; Spinelli, G. P. - 01a Articolo in rivista
paper: CANCERS (Basel: MDPI) pp. 1-11 - issn: 2072-6694 - wos: WOS:000643965000001 (14) - scopus: 2-s2.0-85104330173 (16)